Physician profile
Andrew Fontaine
NPI 1417484742
$15,857.76
in general payments reported to CMS, 2019-2025
11 companies · $5,985 in 2025
The $5,985 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,870 · 2024: $7,003 · 2025: $5,985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $3,801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,056.64 |
| Food and Beverage | $3,801.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $5,600.55 | 2023-2025 | Xlif, Excelsiusgps Robotic Navigation System, Prone Lateral |
| Medtronic, INC. | $3,180.32 | 2023-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Clydesdale Ptc Spinal System, Mazor X System |
| Si-Bone, INC. | $2,184.26 | 2023-2025 | |
| Life Spine, INC. | $1,619.31 | 2024 | Arx, Prolift Lateral Helo, Trulift |
| Arthrex, INC. | $1,413.27 | 2025 | |
| Fortis Surgical, LLC | $1,064.87 | 2024-2025 | |
| Depuy Synthes Sales INC. | $302.59 | 2023-2025 | Teligen, Velys, Conduit |
| Cerapedics INC. | $189.55 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Nuvasive, INC. | $154.92 | 2023 | Xlif |
| Carlsmed, INC. | $116.66 | 2023 | Aprevo |
| Orthofix Medical, INC. | $31.46 | 2023-2024 | Spinal-Stim, Spinal-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Fontaine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.